Home

AboutAI Assistant Contact Us

MembersCareer

|

MODULEN IBD

  • Generic name
    MODULEN IBD

    [Enteral Nutrition Therapy]

  • Highest phase

    N/A

    Background

    Indications

    Clinical Trials

    FDA-Labels

    News

    Patents

    Publications

Background on Modulen IBD: Modulen IBD is a specialized enteral liquid diet developed by Nestle Healthsciences for the dietary management of inflammatory bowel disease (IBD), including Crohn's disease. It is designed to provide complete and balanced nutrition specifically formulated for patients with IBD. Modulen IBD is rich in bioactive components such as TGF-beta, which has been shown to have immunomodulatory properties and is thought to have anti-inflammatory effects. Mechanism of Action: Modulen IBD exerts its therapeutic effects by providing essential nutrients in a form that is easily absorbed by the gastrointestinal tract. It has been suggested that the exclusive use of Modulen IBD as a sole source of nutrition can induce remission in IBD patients. Additionally, the use of Modulen IBD has been associated with improved growth parameters in pediatric patients and has shown potential in promoting mucosal healing and modulating the gut microbiota. Treatment Indications: Modulen IBD is indicated for the dietary management of IBD, particularly in pediatric patients. It is commonly used as a form of enteral nutrition therapy, either as the sole source of nutrition or as a supplementary nutritional support. Studies have shown that Modulen IBD may be effective in inducing and maintaining remission in patients with IBD, and it is considered a suitable alternative to pharmacological treatments such as corticosteroids. Other Relevant Information: Research has suggested that Modulen IBD may contribute to the reduction of inflammatory markers, improvement in growth parameters, and modulation of the gut microbiota in IBD patients. It is typically administered via an enteral feeding tube or as a supplement to the regular diet, depending on the specific treatment protocol. Modulen IBD's role in the management of IBD, particularly as a maintenance therapy, is being actively explored in clinical trials to further establish its long-term efficacy and safety in reducing the rate of relapses in patients with unstable CD.

To

No Data

No Data

Results Posted

No Data